Humira ^*

Humira is administered as an injection just under the skin, a process called subcutaneous injection. Many patients learn to self-inject Humira at home using a pre-filled pen or syringe. Your doctor will show you how to do it correctly. The first dose is often given in a clinical setting to ensure you are comfortable with the process and to monitor for any immediate reactions.

Humira's timeline for effectiveness can vary depending on the condition being treated. Some patients with arthritis may notice improvements within two to four weeks. For conditions like Crohn's disease, it may take four to eight weeks to experience significant relief. It is important to continue your treatment as prescribed by your healthcare provider, even if you do not see immediate results.

Humira does not have a direct, severe interaction with alcohol, but caution is advised. Both heavy alcohol use and Humira can affect the liver, so combining them might increase risks. It is best to discuss your alcohol consumption with your doctor. They can provide personalized advice based on your overall health and liver function to ensure your treatment remains safe and effective.

Humira should be taken exactly as prescribed. If you miss a dose, take it as soon as you remember. Then, take your next dose at the regularly scheduled time. However, if it is almost time for your next scheduled dose, skip the missed one entirely. Do not take a double dose to make up for the one you missed. Contact your doctor or pharmacist if you are unsure what to do.

Humira must be stored in a refrigerator between 36°F to 46°F (2°C to 8°C). Do not freeze the medication. You should keep it in its original carton to protect it from light. If necessary for travel, Humira can be kept at room temperature (up to 77°F or 25°C) for a maximum of 14 days. After being at room temperature for 14 days, it must be discarded if unused.

Humira can lower your immune system's ability to fight infections. This means you may be more susceptible to getting new infections or worsening of an existing one. Tell your doctor immediately if you develop any signs of infection, such as fever, cough, or chills. Your doctor will screen you for tuberculosis (TB) before you start treatment, as Humira can reactivate a latent TB infection.

Humira is not directly linked to weight gain as a common side effect in clinical trials. However, some patients may experience weight changes. For example, if Humira effectively treats a condition like Crohn's disease, your appetite and ability to absorb nutrients may improve, which could lead to healthy weight gain. If you notice any significant or unexpected weight changes, you should discuss them with your doctor.

Humira may be prescribed during pregnancy if your doctor decides the benefits clearly outweigh the potential risks to the fetus. The medication can cross the placenta and be present in newborn infants. It is very important to discuss this with your doctor if you are pregnant or planning to become pregnant. Only small amounts may pass into breast milk, but the effects are not fully known.

Humira's most common side effects are reactions at the injection site. This can include redness, swelling, itching, or pain. Other frequent side effects may include upper respiratory infections (like a cold or sinus infection), headaches, and rashes. These effects are usually mild to moderate and often resolve on their own. If any side effect persists or becomes bothersome, you should contact your healthcare provider.

Humira may impact how your body responds to immunizations. You should not receive any 'live' vaccines while taking Humira, as they contain a weakened form of a germ. Examples include the measles, mumps, rubella (MMR) vaccine and the nasal spray flu vaccine. It is highly recommended to get up-to-date on all your necessary vaccinations before you start your Humira treatment.

Humira has a warning about a potential increased risk of certain types of cancer, including lymphoma and skin cancer. This is a rare risk associated with how the medication affects the immune system. Your doctor will carefully weigh the potential risks and benefits with you before you start treatment. They may also recommend that you perform regular skin checks to monitor for any changes while you are taking Humira.

Humira does not commonly cause hair loss, but some people have reported it. In some situations, hair loss may be a symptom of the underlying autoimmune disease itself rather than a side effect of the medication. Rarely, Humira can trigger a new autoimmune reaction that may cause hair loss. If you experience unusual hair thinning or loss while on this treatment, consult your doctor.

Humira has a 'black box warning,' which is the FDA's most serious alert for a medication. It highlights two major risks. The first is an increased risk of serious infections that could lead to hospitalization or death. The second is a potential for an increased risk of developing certain cancers, such as lymphoma. Your doctor will carefully evaluate these risks before prescribing Humira for you.

Humira provides relief for psoriatic arthritis by targeting and blocking TNF-alpha, which is a key driver of inflammation. By inhibiting this protein, Humira reduces joint pain, stiffness, and swelling. It can also help clear up the skin plaques associated with psoriasis that often accompany this form of arthritis. This action helps to slow the progression of joint damage and improve overall physical function.

Humira treatment should not be stopped suddenly without first consulting your doctor. Abruptly discontinuing the medication can cause a flare-up or a significant worsening of your underlying autoimmune condition. Your doctor will provide guidance on the best course of action if you need to stop or change your treatment. This may involve tapering the dose or switching to a different medication.